Clinical Trials Logo

Clinical Trial Summary

The objective of this trial is to scientifically evaluate the efficacy of PEEK cranioplasty and titanium cranioplasty. The primary objective is to compare the rate of implant failure (defined as infection, implant exposure and other causes requiring removal of the implanted material) at any time within 12 months after cranioplasty. The secondary objective is to compare the complication rates and neurological function recover following cranioplasty. Complication events after cranioplasty are investigated within 6 months after surgery and neurological function is evaluated at 3, 6 and 12 months after cranioplasty.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05416684
Study type Observational
Source RenJi Hospital
Contact Zhiyi Zhou
Phone 15921055766
Email zzyhenry@sina.com
Status Recruiting
Phase
Start date June 2022
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05291754 - 3D Printed PEEK Implants for Cranioplasty N/A
Recruiting NCT05603949 - Development of Three-dimensional Deep Learning for Automatic Design of Skull Implants
Completed NCT04707404 - Comparison of Cranioplasty With PEEK and Titanium